Skip to main content
. 2018 Jan 23;10:75–82. doi: 10.2147/CEOR.S144300

Table 1.

Characteristics of the enrolled patients in the treated and untreated groups

Characteristics Patients (n), N=455 Study groups
p-value between groups
Oscillococcinum (N=246) Control (N=209)
Gender 0.0532
Male 219 115 104
Female 236 131 105
Age classes 0.0193
Adults 286 139 147
Pediatric 169 107 62
Diagnosis <0.001
RRI 107 88 19
 Adults 0 0 0
 Pediatric 107 88 19
RTI 114 43 71 0.0015
 Adults 89 41 48
 Pediatric 25 2 23
Allergic respiratory diseases 65 24 41 0.0526
 Adults 51 22 29
 Pediatric 14 2 12
Asthma 102 55 47 0.2157
 Adults 79 40 39
 Pediatric 23 15 8
COPD 67 36 31 0.3731
 Adults 67 36 31
 Pediatric 0 0 0

Notes: Oscillococcinum® manufactured by Boiron, Messimy, France. Adults: >12 years; pediatric: ≤12 years.

Abbreviations: RRI, recurrent respiratory infection; RTI, respiratory tract infection.